Product Name | MF | CAS | Details |
---|
TRK-IN-15 | C19H20FN5O | 1365213-20-2 | Details |
5-HT7 agonist 2 | C23H29N3O | 1206846-61-8 | Details |
(S)-Baxdrostat | C22H25N3O2 | 1428652-16-7 | Details |
Carpro-AM1 | C21H18ClN3O | 2499489-76-6 | Details |
hCAIX/XII-IN-4 | C20H16N2O5 | 1119200-33-7 | Details |
LmCPB-IN-1 | C18H30N6O2 | 2151025-98-6 | Details |
Anabolic agent-1 | C15H22N2O6S | 2439179-74-3 | Details |
SSTR4 agonist 3 | C18H24N4OS | 2744188-34-7 | Details |
Stemphyperylenol | C20H16O6 | 102694-33-7 | Details |
TRK-IN-16 | C19H20FN5O | 1365212-81-2 | Details |
P163-0892 | C19H20N2O3S | 1574576-45-6 | Details |
PTG-0861 | C15H9F5N2O3 | 2494082-34-5 | Details |
Cdc7-IN-8 | C19H21N5O2 | 2606780-38-3 | Details |
Anticancer agent 74 | C25H21NO | 2242503-82-6 | Details |
ZLD2218 | C22H18N4O | 2713974-32-2 | Details |
Colletotrichalactones A | C20H20O6 | 2751633-79-9 | Details |
EGFR-IN-64 | C20H21N3O3 | 2416924-93-9 | Details |
Protein kinase D inhibitor 1 | C19H21N7 | 2489320-03-6 | Details |
JAK-2/3-IN-2 | C19H19ClN2OS | 2170398-48-6 | Details |
IDO1/TDO-IN-3 | C16H6ClF2N3O2 | 2347579-03-5 | Details |
MAO-B-IN-12 | C22H30O4 | 2394733-97-0 | Details |
PAK4-IN-2 | C18H21ClN6 | 2488706-33-6 | Details |
ABAI-30 | C17H13N7O2 | 2757957-25-6 | Details |
Topoisomerase II inhibitor 3 | C18H20N4O4 | 99140-25-7 | Details |
hCAI/II-IN-2 | C12H12N4O5S2 | 2480283-75-6 | Details |
Antiparasitic agent-7 | C18H15N3O5 | 2253996-75-5 | Details |
Xanthine oxidoreductase-IN-2 | C21H19N3O2 | 2396612-45-4 | Details |
EGFR-IN-68 | C24H22N2O | 2416925-03-4 | Details |
PDE4-IN-11 | C21H19FN2O2 | 524734-30-3 | Details |
CBR-6672 | C17H20FN3O2S | 2225885-40-3 | Details |
CO delivery molecule 1 | C23H21NO3 | 1972616-04-8 | Details |
Antibacterial agent 121 | C18H22N2O3S | 474099-18-8 | Details |
α-Glucosidase-IN-16 | C22H18FNS | 1606142-34-0 | Details |
R-PSOP | C20H22N4O2 | 1185189-97-2 | Details |
Antitumor agent-57 | C20H15NO5 | 2432823-48-6 | Details |
Cdc7-IN-14 | C18H20N4O2S | 2764866-21-7 | Details |
PARP1-IN-9 | C18H21N3O5 | 2494000-71-2 | Details |
BET-IN-7 | C18H12ClN3OS | 303985-05-9 | Details |
Anti-inflammatory agent 17 | C20H23NO5 | 2763226-84-0 | Details |
COX-2/5-LOX-IN-3 | C17H16ClN3O2S | 2481484-51-7 | Details |
BChE-IN-13 | C24H28N2O | 2700896-73-5 | Details |
CDK1/Cyc B-IN-1 | C14H12ClN3O2S2 | 2459916-56-2 | Details |
MmpL3-IN-1 | C20H21F2N3O | 2290534-93-7 | Details |
α-Glucosidase-IN-20 | C23H21NOS | 420809-56-9 | Details |
Anti-infective agent 5 | C18H13N5O3 | 2738381-47-8 | Details |
MIF-IN-5 | C18H14FN5O2 | 2582755-31-3 | Details |
NSC114126 | C22H20O4 | 24909-18-0 | Details |
MRGPRX4 modulator-2 | C15H9ClF4O3 | 2492595-24-9 | Details |
Antituberculosis agent-1 | C21H21NO4 | 2411740-98-0 | Details |
CA224 | C24H22N2O | 883561-04-4 | Details |
PDE11-IN-1 | C16H10ClN3O3S | 522652-41-1 | Details |
NAT2-IN-1 | C19H20N4O3 | 856005-97-5 | Details |
HIF-2α-IN-6 | C15H13F4NO3S | 2755401-07-9 | Details |
Cdc7-IN-19 | C19H21N5O2 | 2606780-39-4 | Details |
Anti-osteoporosis agent-1 | C20H19ClN2O2 | 2761577-50-6 | Details |
COX-1/2-IN-1 | C15H10BrClN2O | 2358849-47-3 | Details |
Antitubercular agent-17 | C14H12BrN5O | 2328751-33-1 | Details |
Antitubercular agent-27 | C14H8BrN3O3 | 2460651-09-4 | Details |
5-HT6/5-HT2A receptor ligand-2 | C20H18FN3O2 | 2411088-16-7 | Details |
Irdabisant hydrochloride | C18H24ClN3O2 | 1005398-61-7 | Details |
hCAIX-IN-6 | C18H12N2O4S | 2451479-86-8 | Details |
Pantothenate kinase-IN-1 | C21H25N5O | 1024168-48-6 | Details |
APX2039 | C20H15FN4O2 | 2342606-49-7 | Details |
ARN25068 | C19H18N6S | 2649882-80-2 | Details |
Hepcidin antagonist-1 | C16H13Cl2N5 | 338965-09-6 | Details |
Antibacterial agent 97 | C19H23N5S | 1714961-61-1 | Details |
Antibacterial agent 96 | C18H15Cl2NO2 | 2413006-62-7 | Details |
p53 Activator 2 | C20H21N5O2 | 2338764-89-7 | Details |
Antitubercular agent-18 | C14H12BrN5O | 1308272-99-2 | Details |
Antiparasitic agent-2 | C20H17N3O3 | 2494277-80-2 | Details |
FWM-3 | C16H16N6O2S | 714923-33-8 | Details |
Orbofiban | C17H23N5O4 | 163250-90-6 | Details |
Antileishmanial agent-3 | C14H13ClN6O4 | 2755930-28-8 | Details |
HIF-1α-IN-2 | C21H19N3OS | 2762315-06-8 | Details |
Antiparasitic agent-8 | C17H22FN3O4 | 2538594-33-9 | Details |
DC-CPin7 | C19H22N2O5 | 893781-17-4 | Details |
ARN1468 | C16H17F3N4O2 | 1381459-14-8 | Details |
COX-2-IN-19 | C18H18N4O2S | 2497530-12-6 | Details |
hDHODH-IN-9 | C21H21NO4 | 133676-47-8 | Details |
MRGPRX4 modulator-1 | C16H13ClF3NO3 | 2492596-61-7 | Details |
HFI-419 | C19H18N2O5 | 1110650-72-0 | Details |
Cdc7-IN-13 | C18H20N4O2S | 2764866-23-9 | Details |
AChE/BChE/BACE-1-IN-1 | C19H21F3N2O | 1321361-13-0 | Details |
CXCR2 antagonist 3 | C17H15FN2O4S | 2647464-92-2 | Details |
Tubulin inhibitor 12 | C24H20N2O | 92575-00-3 | Details |
LDHA/PDKs-IN-1 | C19H21FN2O4 | 2490699-40-4 | Details |
mGluR2 modulator 4 | C18H18BrN3 | 2582758-47-0 | Details |
MAO-B-IN-11 | C22H32O3 | 192383-78-1 | Details |
MAT2A-IN-5 | C17H12ClF3N2O | 2756458-55-4 | Details |
5-HT6/5-HT2A receptor ligand-1 | C21H19FN2O2 | 2411088-07-6 | Details |
Antibacterial agent 94 | C21H21FO4 | 1666134-58-2 | Details |
Tubulin polymerization-IN-27 | C22H20N2O2 | 2462030-32-4 | Details |
Aβ-IN-5 | C21H20N2O3 | 2417977-65-0 | Details |
hCAXII-IN-1 | C20H17NO5 | 2451479-66-4 | Details |
CXCR4 antagonist 8 | C21H26N6 | 2304750-84-1 | Details |
DNA-PK-IN-6 | C19H21N7O | 2711810-41-0 | Details |
EP3 antagonist 3 | C21H18N2O4 | 1227827-88-4 | Details |
IDO1/TDO-IN-1 | C21H16O6 | 2379527-72-5 | Details |
F-17 | C17H15BrO4 | 1572464-22-2 | Details |
D18 | C21H28N6 | 2230218-36-5 | Details |
Product Total: Product Page: | ||||
107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 |